Exact Mass: 520.3777

Exact Mass Matches: 520.3777

Found 164 metabolites which its exact mass value is equals to given mass value 520.3777, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cyclopassifloic acid B

15-[5,6-dihydroxy-5-(propan-2-yl)hexan-2-yl]-4,6-dihydroxy-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

C31H52O6 (520.3764)


Cyclopassifloic acid B is found in fruits. Cyclopassifloic acid B is a constituent of Passiflora edulis (passion fruit). Constituent of Passiflora edulis (passion fruit). Cyclopassifloic acid B is found in fruits.

   

Chenodeoxycholyllysine

6-Amino-2-[(4-{5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0,.0,]heptadecan-14-yl}-1-hydroxypentylidene)amino]hexanoate

C30H52N2O5 (520.3876)


Chenodeoxycholyllysine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Chenodeoxycholyllysine consists of the bile acid chenodeoxycholic acid conjugated to the amino acid Lysine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Chenodeoxycholyllysine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Chenodeoxycholyllysine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

   

Deoxycholyllysine

6-Amino-2-[(4-{5,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0,.0,]heptadecan-14-yl}-1-hydroxypentylidene)amino]hexanoate

C30H52N2O5 (520.3876)


Deoxycholyllysine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Deoxycholyllysine consists of the bile acid deoxycholic acid conjugated to the amino acid Lysine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Deoxycholyllysine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Deoxycholyllysine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

   

DG(8:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C31H52O6 (520.3764)


DG(8:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C31H52O6 (520.3764)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C31H52O6 (520.3764)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoic acid

C31H52O6 (520.3764)


DG(8:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoic acid

C31H52O6 (520.3764)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoic acid

C31H52O6 (520.3764)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl octanoic acid

C31H52O6 (520.3764)


DG(8:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/8:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propan-2-yl octanoic acid

C31H52O6 (520.3764)


DG(20:3(5Z,11Z,14Z)-O(8,9)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

(2R)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl octanoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/8:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl octanoic acid

C31H52O6 (520.3764)


DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

(2S)-3-Hydroxy-2-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl octanoic acid

C31H52O6 (520.3764)


DG(8:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/8:0/0:0)

(2S)-1-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propan-2-yl octanoic acid

C31H52O6 (520.3764)


DG(20:3(8Z,11Z,14Z)-O(5,6)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

(2R)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl octanoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/8:0)

(2S)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl octanoic acid

C31H52O6 (520.3764)


DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (5R,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

(2R)-2-hydroxy-3-(octanoyloxy)propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoate

C31H52O6 (520.3764)


DG(8:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/8:0)

(2S)-2-hydroxy-3-(octanoyloxy)propyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoate

C31H52O6 (520.3764)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

(2S)-1-hydroxy-3-(octanoyloxy)propan-2-yl (5Z,8Z,10E,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C31H52O6 (520.3764)


DG(8:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/8:0/0:0)

(2S)-3-hydroxy-2-(octanoyloxy)propyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(8:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C31H52O6 (520.3764)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Hippuristerol F

Hippuristerol F

C31H52O6 (520.3764)


   

Cordianol C

Cordianol C

C31H52O6 (520.3764)


   

Cordianol I

Cordianol I

C31H52O6 (520.3764)


   

21-O-Methyltoosendanpentol

21-O-Methyltoosendanpentol

C31H52O6 (520.3764)


   

21-O-methyl toosendanpentol|21-O-methyltoosendapentol

21-O-methyl toosendanpentol|21-O-methyltoosendapentol

C31H52O6 (520.3764)


   

crassumtocopherol B

crassumtocopherol B

C31H52O6 (520.3764)


   

halicrasterol B

halicrasterol B

C31H52O6 (520.3764)


   

agladoral B

agladoral B

C31H52O6 (520.3764)


   

Lysine conjugated deoxycholic acid putative

Lysine conjugated deoxycholic acid putative

C30H52N2O5 (520.3876)


   

Cyclopassifloic acid B

15-[5,6-dihydroxy-5-(propan-2-yl)hexan-2-yl]-4,6-dihydroxy-7,12,16-trimethylpentacyclo[9.7.0.0^{1,3}.0^{3,8}.0^{12,16}]octadecane-7-carboxylic acid

C31H52O6 (520.3764)


   

DG(8:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

DG(8:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C31H52O6 (520.3764)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/8:0/0:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

DG(8:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C31H52O6 (520.3764)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/8:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

DG(8:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C31H52O6 (520.3764)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/8:0/0:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

DG(8:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C31H52O6 (520.3764)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/8:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

DG(8:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C31H52O6 (520.3764)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/8:0/0:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

DG(8:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C31H52O6 (520.3764)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/8:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

DG(8:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C31H52O6 (520.3764)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/8:0/0:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

DG(8:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C31H52O6 (520.3764)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/8:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/8:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/8:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

DG(8:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C31H52O6 (520.3764)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/8:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

DG(8:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C31H52O6 (520.3764)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/8:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/8:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/8:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/8:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/8:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/8:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/8:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

DG(8:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/8:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

DG(8:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/8:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

DG(8:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/8:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

DG(8:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/8:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

DG(8:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/8:0/0:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

DG(8:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C31H52O6 (520.3764)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/8:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

DG(8:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C31H52O6 (520.3764)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/8:0/0:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

DG(8:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C31H52O6 (520.3764)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/8:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/8:0)

C31H52O6 (520.3764)


   

DG(8:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

DG(8:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C31H52O6 (520.3764)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/8:0/0:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/8:0/0:0)

C31H52O6 (520.3764)


   

DG(8:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

DG(8:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C31H52O6 (520.3764)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/8:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/8:0)

C31H52O6 (520.3764)


   

4-tert-butyl-N-[3-[4-[3-[[(4-tert-butylphenyl)-oxomethyl]amino]propyl]-1-piperazinyl]propyl]benzamide

4-tert-butyl-N-[3-[4-[3-[[(4-tert-butylphenyl)-oxomethyl]amino]propyl]-1-piperazinyl]propyl]benzamide

C32H48N4O2 (520.3777)


   

1,2-dihexanoyl-3-(7Z,10Z,13Z-hexadecatrienoyl)-glycerol

1,2-dihexanoyl-3-(7Z,10Z,13Z-hexadecatrienoyl)-glycerol

C31H52O6 (520.3764)


   

2-[hydroxy-[(2R)-2-hydroxy-3-[(1Z,12Z)-nonadeca-1,12-dienoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2R)-2-hydroxy-3-[(1Z,12Z)-nonadeca-1,12-dienoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C27H55NO6P+ (520.3767)


   

2-[hydroxy-[2-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C27H55NO6P+ (520.3767)


   

TG(28:3)

TG(4:0_11:3_13:0)

C31H52O6 (520.3764)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   
   
   
   

ST 25:1;O;Hex

ST 25:1;O;Hex

C31H52O6 (520.3764)


   

7-(acetyloxy)-1-(3,6-dihydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

7-(acetyloxy)-1-(3,6-dihydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

C31H52O6 (520.3764)


   

(1s,3br,4r,5as,7r,9as,9bs,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

(1s,3br,4r,5as,7r,9as,9bs,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

C31H52O6 (520.3764)


   

methyl (1r,2r,4as,6ar,6br,8ar,10s,12ar,12br,14ar,14bs)-1,10-dihydroxy-9,9-bis(hydroxymethyl)-1,2,6a,6b,12a-pentamethyl-hexadecahydropicene-4a-carboxylate

methyl (1r,2r,4as,6ar,6br,8ar,10s,12ar,12br,14ar,14bs)-1,10-dihydroxy-9,9-bis(hydroxymethyl)-1,2,6a,6b,12a-pentamethyl-hexadecahydropicene-4a-carboxylate

C31H52O6 (520.3764)


   

3,4-dihydroxycinnamic acid; behenic acid

3,4-dihydroxycinnamic acid; behenic acid

C31H52O6 (520.3764)


   

(3s,4s,5e)-6-[(1r,2s,3r,5r,6s,9r,10r,13s,15s,17s)-3-hydroxy-17-methoxy-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecan-6-yl]-2-methylhept-5-ene-2,3,4-triol

(3s,4s,5e)-6-[(1r,2s,3r,5r,6s,9r,10r,13s,15s,17s)-3-hydroxy-17-methoxy-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecan-6-yl]-2-methylhept-5-ene-2,3,4-triol

C31H52O6 (520.3764)


   

21-o-methyl toosendanpentaol

NA

C31H52O6 (520.3764)


{"Ingredient_id": "HBIN003594","Ingredient_name": "21-o-methyl toosendanpentaol","Alias": "NA","Ingredient_formula": "C31H52O6","Ingredient_Smile": "CC1(C(CCC2(C1CC(C3(C2CCC4(C3=CCC4C5CC(OC5OC)C(C(C)(C)O)O)C)C)O)C)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31684","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

21-o-methyl toosendanpentol

21- o -methyltoosendanpentol

C31H52O6 (520.3764)


{"Ingredient_id": "HBIN003595","Ingredient_name": "21-o-methyl toosendanpentol","Alias": "21- o -methyltoosendanpentol","Ingredient_formula": "C31H52O6","Ingredient_Smile": "CC1(C(CCC2(C1CC(C3(C2CCC4(C3=CCC4C5CC(OC5OC)C(C(C)(C)O)O)C)C)O)C)O)C","Ingredient_weight": "520.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT16725","TCMID_id": "14756","TCMSP_id": "NA","TCM_ID_id": "8771","PubChem_id": "101437871","DrugBank_id": "NA"}

   

(4s,5e)-6-[(1r,2s,3r,5r,6s,9r,10r,13s,15s)-3-hydroxy-17-methoxy-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecan-6-yl]-2-methylhept-5-ene-2,3,4-triol

(4s,5e)-6-[(1r,2s,3r,5r,6s,9r,10r,13s,15s)-3-hydroxy-17-methoxy-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecan-6-yl]-2-methylhept-5-ene-2,3,4-triol

C31H52O6 (520.3764)


   

(1r,2s,3s)-1-[(1r,2s,3's,3as,3br,5as,7r,9as,9bs,11as)-2,7-dihydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-4-hydroxy-2,3,4-trimethylpentyl acetate

(1r,2s,3s)-1-[(1r,2s,3's,3as,3br,5as,7r,9as,9bs,11as)-2,7-dihydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-4-hydroxy-2,3,4-trimethylpentyl acetate

C31H52O6 (520.3764)


   

1-{2,7-dihydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-4-hydroxy-2,3,4-trimethylpentyl acetate

1-{2,7-dihydroxy-3',9a,11a-trimethyl-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-4-hydroxy-2,3,4-trimethylpentyl acetate

C31H52O6 (520.3764)


   

(1r,2s,3r,5r,6s,9r,10r,13r,15s)-6-[(2e,4s,5s)-4,5-dihydroxy-6-methoxy-6-methylhept-2-en-2-yl]-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecane-3,15-diol

(1r,2s,3r,5r,6s,9r,10r,13r,15s)-6-[(2e,4s,5s)-4,5-dihydroxy-6-methoxy-6-methylhept-2-en-2-yl]-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecane-3,15-diol

C31H52O6 (520.3764)


   

(1s,3s,4s,6s,7s,8r,11s,12s,15r,16r)-15-[(2r,5s)-5,6-dihydroxy-5-isopropylhexan-2-yl]-4,6-dihydroxy-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

(1s,3s,4s,6s,7s,8r,11s,12s,15r,16r)-15-[(2r,5s)-5,6-dihydroxy-5-isopropylhexan-2-yl]-4,6-dihydroxy-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

C31H52O6 (520.3764)


   

(2r)-2,5,7,8-tetramethyl-2-[(4r,8r,11s)-8,11,12-trihydroxy-4,8,12-trimethyltridecyl]-3,4-dihydro-1-benzopyran-6-yl acetate

(2r)-2,5,7,8-tetramethyl-2-[(4r,8r,11s)-8,11,12-trihydroxy-4,8,12-trimethyltridecyl]-3,4-dihydro-1-benzopyran-6-yl acetate

C31H52O6 (520.3764)


   

6-(4,5-dihydroxy-6-methoxy-6-methylhept-2-en-2-yl)-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecane-3,15-diol

6-(4,5-dihydroxy-6-methoxy-6-methylhept-2-en-2-yl)-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecane-3,15-diol

C31H52O6 (520.3764)


   

(1r,3ar,3br,5s,5ar,7r,9ar,9bs,11as)-7-(acetyloxy)-1-[(2s,3s)-3,6-dihydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

(1r,3ar,3br,5s,5ar,7r,9ar,9bs,11as)-7-(acetyloxy)-1-[(2s,3s)-3,6-dihydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

C31H52O6 (520.3764)


   

6-{3-hydroxy-17-methoxy-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecan-6-yl}-2-methylhept-5-ene-2,3,4-triol

6-{3-hydroxy-17-methoxy-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecan-6-yl}-2-methylhept-5-ene-2,3,4-triol

C31H52O6 (520.3764)


   

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2s,3r,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2s,3r,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

C31H52O6 (520.3764)


   

1-[5-(1,2-dihydroxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

1-[5-(1,2-dihydroxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

C31H52O6 (520.3764)


   

(1r,2s,3r,5r,6s,9r,10r,13r,15s)-6-[(2e,4s)-4,5-dihydroxy-6-methoxy-6-methylhept-2-en-2-yl]-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecane-3,15-diol

(1r,2s,3r,5r,6s,9r,10r,13r,15s)-6-[(2e,4s)-4,5-dihydroxy-6-methoxy-6-methylhept-2-en-2-yl]-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecane-3,15-diol

C31H52O6 (520.3764)


   

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2r,3r,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2r,3r,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

C31H52O6 (520.3764)


   

(1r,2s,3r,5r,6s,9r,10r,13r,15s)-6-[(2e,4s,5r)-4,5-dihydroxy-6-methoxy-6-methylhept-2-en-2-yl]-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecane-3,15-diol

(1r,2s,3r,5r,6s,9r,10r,13r,15s)-6-[(2e,4s,5r)-4,5-dihydroxy-6-methoxy-6-methylhept-2-en-2-yl]-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecane-3,15-diol

C31H52O6 (520.3764)


   

(1s,3br,4r,5ar,7r,9as,9bs,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

(1s,3br,4r,5ar,7r,9as,9bs,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

C31H52O6 (520.3764)


   

methyl 1,10-dihydroxy-9,9-bis(hydroxymethyl)-1,2,6a,6b,12a-pentamethyl-hexadecahydropicene-4a-carboxylate

methyl 1,10-dihydroxy-9,9-bis(hydroxymethyl)-1,2,6a,6b,12a-pentamethyl-hexadecahydropicene-4a-carboxylate

C31H52O6 (520.3764)